| systematic review | Q1504425 |
| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Umberto D'Alessandro | Q53680267 |
| Jean-Pierre Van Geertruyden | Q60227625 | ||
| Christine Manyando | Q85982640 | ||
| Eric Njunju | Q127378801 | ||
| P2093 | author name string | Eric M Njunju | |
| P2860 | cites work | Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa | Q21032444 |
| Trimethoprim, a sulphonamide potentiator | Q24676377 | ||
| Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum | Q27861947 | ||
| Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study | Q28139876 | ||
| Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine-pyrimethamine intermittent preventive therapy during pregnancy in Malawi | Q28387497 | ||
| Co-trimoxazole in HIV-1 infection | Q58496607 | ||
| Applications of RSS in Health Sciences Libraries | Q58551308 | ||
| Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trial | Q64131962 | ||
| Folate and vitamin B12 deficiencies: proceedings of a WHO technical consultation held 18-21 October, 2005, in Geneva, Switzerland. Introduction | Q81796018 | ||
| Impact of permethrin-treated bed nets on malaria, anemia, and growth in infants in an area of intense perennial malaria transmission in western Kenya | Q46741853 | ||
| Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults? | Q47877517 | ||
| In vitro susceptibility of Plasmodium falciparum malaria to pyrimethamine, sulfadoxine, trimethoprim and sulfamethoxazole, singly and in combination | Q47912389 | ||
| Malaria, HIV and pregnancy | Q47921390 | ||
| The effect of dual infection with HIV and malaria on pregnancy outcome in western Kenya | Q47923816 | ||
| Association between malaria and CD4 cell count decline among persons with HIV. | Q48020831 | ||
| Trimethoprim-Sulphamethoxazole: Comparative Study in Urinary Infection in Hospital | Q49166427 | ||
| Consequences of HIV infection on malaria and therapeutic implications: a systematic review | Q37893776 | ||
| Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort | Q38872771 | ||
| Co-trimoxazole, cART, and non-AIDS infectious diseases | Q38875931 | ||
| Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children | Q38877477 | ||
| Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members. | Q38879071 | ||
| Mortality in HIV-infected and uninfected children of HIV-infected and uninfected mothers in rural Uganda | Q38879544 | ||
| Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study | Q38879589 | ||
| Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family members | Q38880788 | ||
| Principal role of dihydropteroate synthase mutations in mediating resistance to sulfadoxine-pyrimethamine in single-drug and combination therapy of uncomplicated malaria in Uganda. | Q38881371 | ||
| Asymptomatic parasitaemia as a risk factor for symptomatic malaria in a cohort of Ugandan children | Q38881807 | ||
| Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria. | Q38882569 | ||
| Community-acquired pneumonia in Ugandan adults: short-term parenteral ampicillin therapy for bacterial pneumonia | Q38885092 | ||
| Resistance in vivo of Plasmodium falciparum to co-trimoxazole in western Uganda | Q38887123 | ||
| Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus. | Q38953092 | ||
| The safety and efficacy of sulfadoxine-pyrimethamine, amodiaquine, and their combination in the treatment of uncomplicated Plasmodium falciparum malaria | Q40573522 | ||
| Co-trimoxazole compared with sulfadoxine-pyrimethamine in the treatment of uncomplicated malaria in Kenyan children | Q40589232 | ||
| Human immunodeficiency virus seropositivity and malaria as risk factors for third-trimester anemia in asymptomatic pregnant women in western Kenya. | Q40593081 | ||
| Dynamics of P. falciparum gametocytemia in symptomatic patients in an area of intense perennial transmission in Tanzania. | Q41919604 | ||
| Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria | Q41920138 | ||
| Gametocytemia and infectivity to mosquitoes of patients with uncomplicated Plasmodium falciparum malaria attacks treated with chloroquine or sulfadoxine plus pyrimethamine. | Q41921699 | ||
| Increased carriage of trimethoprim/sulfamethoxazole-resistant Streptococcus pneumoniae in Malawian children after treatment for malaria with sulfadoxine/pyrimethamine | Q41921885 | ||
| An evaluation of co-trimoxazole in the treatment of Plasmodium falciparum malaria | Q41923368 | ||
| Trimethoprim plus sulphamethoxazole compared with chloroquine in the treatment and suppression of malaria in African schoolchildren | Q41937032 | ||
| Neural tube defects in relation to use of folic acid antagonists during pregnancy | Q43625422 | ||
| Initiating co-trimoxazole prophylaxis in HIV-infected patients in Africa: an evaluation of the provisional WHO/UNAIDS recommendations | Q43646776 | ||
| The long-term impact of HIV and orphanhood on the mortality and physical well-being of children in rural Malawi | Q43658270 | ||
| Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine | Q43758891 | ||
| Voluntary counselling, HIV testing and adjunctive cotrimoxazole reduces mortality in tuberculosis patients in Thyolo, Malawi | Q43791341 | ||
| The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study | Q43819085 | ||
| Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial. Cotrimo-CI Study Group | Q43836224 | ||
| Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria | Q43864384 | ||
| The effects of maternal helminth and malaria infections on mother-to-child HIV transmission | Q43989249 | ||
| Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria | Q44030140 | ||
| Effect of sulphamethoxazole-trimethoprim on the viability of Plasmodium falciparum gametocytes | Q44157845 | ||
| Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans | Q44391262 | ||
| HIV increases the risk of malaria in women of all gravidities in Kisumu, Kenya | Q44394085 | ||
| Impact of permethrin-treated bed nets on malaria and all-cause morbidity in young children in an area of intense perennial malaria transmission in western Kenya: cross-sectional survey. | Q44635990 | ||
| Second trimester folate status and preterm birth | Q45183496 | ||
| Placental malaria and perinatal transmission of human immunodeficiency virus type 1. | Q45707785 | ||
| Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group | Q45787461 | ||
| Effects of antifolates--co-trimoxazole and pyrimethamine-sulfadoxine--on gametocytes in children with acute, symptomatic, uncomplicated, Plasmodium falciparum malaria | Q46217275 | ||
| Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya | Q46304018 | ||
| Effect of maternal HIV and malaria infection on pregnancy and perinatal outcome in Zimbabwe | Q46348110 | ||
| Predictors of the failure of treatment with trimethoprim-sulfamethoxazole in children with uncomplicated, Plasmodium falciparum malaria | Q46369056 | ||
| Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi | Q46428335 | ||
| Efficacy of trimethoprim-sulfamethoxazole compared with sulfadoxine-pyrimethamine plus erythromycin for the treatment of uncomplicated malaria in children with integrated management of childhood illness dual classifications of malaria and pneumonia. | Q46487573 | ||
| Sensitivity of Plasmodium falciparum in The Gambia to co-trimoxazole | Q46608180 | ||
| Randomized trial of artesunate+amodiaquine, sulfadoxine-pyrimethamine+amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in Tanzania | Q28475232 | ||
| LactMed-new NLM database on drugs and lactation | Q33268591 | ||
| Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review | Q33288230 | ||
| Hematological side effects of co-trimoxazole | Q33450249 | ||
| Plasmodium falciparum dihydrofolate reductase and dihyropteroate synthase mutations and the use of trimethoprim-sulfamethoxazole prophylaxis among persons infected with human immunodeficiency virus | Q33817605 | ||
| Folic acid antagonists during pregnancy and the risk of birth defects. | Q33926560 | ||
| Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance | Q33992235 | ||
| Exposure to anti-infective drugs during pregnancy and the risk of small-for-gestational-age newborns: a case-control study | Q34199799 | ||
| Considerations when prescribing trimethoprim-sulfamethoxazole | Q34223201 | ||
| The burden of malaria in pregnancy in malaria-endemic areas. | Q34292893 | ||
| Does severity of HIV disease in HIV-infected mothers affect mortality and morbidity among their uninfected infants? | Q34313201 | ||
| Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis | Q34355499 | ||
| Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda | Q34359439 | ||
| Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. | Q34482190 | ||
| Effects of folate and vitamin B12 deficiencies during pregnancy on fetal, infant, and child development | Q34595681 | ||
| Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial | Q34748630 | ||
| Low prevalence of Plasmodium falciparum antigenaemia among asymptomatic HAART-treated adults in an urban cohort in Uganda | Q34764823 | ||
| Monitoring of co-trimoxazole concentrations in serum during treatment of pneumocystis carinii pneumonia | Q35120725 | ||
| Reduction in preterm delivery and neonatal mortality after the introduction of antenatal cotrimoxazole prophylaxis among HIV-infected women with low CD4 cell counts | Q35594099 | ||
| Reconsidering empirical cotrimoxazole prophylaxis for infants exposed to HIV infection | Q35839094 | ||
| The contribution of malaria in pregnancy to perinatal mortality | Q35872621 | ||
| The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-saharan Africa. | Q35872624 | ||
| Effect of HIV-1 infection on malaria treatment outcome in Ugandan patients | Q35902649 | ||
| Impact of placental Plasmodium falciparum malaria on pregnancy and perinatal outcome in sub-Saharan Africa: II: effects of placental malaria on perinatal outcome; malaria and HIV. | Q36470408 | ||
| Systematic review of the safety of trimethoprim-sulfamethoxazole for prophylaxis in HIV-infected pregnant women: implications for resource-limited settings | Q36493593 | ||
| Trimethoprim: laboratory and clinical studies | Q36533311 | ||
| Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment | Q36834927 | ||
| The impact of HIV-1 on the malaria parasite biomass in adults in sub-Saharan Africa contributes to the emergence of antimalarial drug resistance | Q36840133 | ||
| Co-trimoxazole prophylaxis in tropical countries in the era of highly active antiretroviral therapy: do we know enough? | Q36896070 | ||
| Sulfadoxine-pyrimethamine impairs Plasmodium falciparum gametocyte infectivity and Anopheles mosquito survival | Q37097339 | ||
| Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease | Q37339874 | ||
| Placental malaria among HIV-infected and uninfected women receiving anti-folates in a high transmission area of Uganda | Q37429678 | ||
| Placental malaria, maternal HIV infection and infant morbidity. | Q37491397 | ||
| Cotrimoxazole, clinical uses and malaria chemotherapy | Q37772878 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Plasmodium falciparum | Q311383 |
| antimalarial | Q521616 | ||
| sulfamethoxazole/trimethoprim | Q898623 | ||
| systematic review | Q1504425 | ||
| amides | Q188777 | ||
| heterocyclic compound | Q193430 | ||
| prevention | Q1717246 | ||
| combination drug | Q1779868 | ||
| Plasmodium falciparum malaria | Q18554672 | ||
| pharmaceutical preparation | Q66089252 | ||
| malaria prevention | Q93598033 | ||
| amine | Q167198 | ||
| malaria | Q12156 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | e56916 | |
| P577 | publication date | 2013-02-22 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review | |
| P478 | volume | 8 |
| Q48241249 | 8-Mercaptoguanine Derivatives as Inhibitors of Dihydropteroate Synthase. |
| Q53679268 | A man with unsuspected marine eosinophilic gastritis. |
| Q28076750 | Antibiotics in malaria therapy: which antibiotics except tetracyclines and macrolides may be used against malaria? |
| Q33736846 | Assessment of the consistency of national-level policies and guidelines for malaria in pregnancy in five African countries |
| Q28084544 | Assessment of the impact of cotrimoxazole prophylaxis on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic review |
| Q38596372 | Co-trimoxazole prophylaxis in adults, including pregnant women, with HIV: a systematic review and meta-analysis |
| Q46302284 | Cost-effectiveness of malaria preventive treatment for HIV-infected pregnant women in sub-Saharan Africa. |
| Q27009235 | Cotrimoxazole prophylactic treatment prevents malaria in children in sub-Saharan Africa: systematic review and meta-analysis |
| Q60924982 | Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial |
| Q26999453 | Drug repurposing and human parasitic protozoan diseases |
| Q36323840 | Effect of HIV and malaria parasites co-infection on immune-hematological profiles among patients attending anti-retroviral treatment (ART) clinic in Infectious Disease Hospital Kano, Nigeria |
| Q28084902 | Effect of cotrimoxazole prophylaxis on malaria occurrence in HIV-infected patients on antiretroviral therapy in sub-Saharan Africa |
| Q35739147 | Effect of cotrimoxazole prophylaxis on the incidence of malaria in HIV-infected children in 2012, in Abidjan, Côte d'Ivoire: a prospective cohort study |
| Q92723500 | Efficacy and safety of dihydroartemisinin-piperaquine for treatment of Plasmodium falciparum uncomplicated malaria in adult patients on antiretroviral therapy in Malawi and Mozambique: an open label non-randomized interventional trial |
| Q35097734 | Frequency of severe malaria and invasive bacterial infections among children admitted to a rural hospital in Burkina Faso |
| Q36759511 | Impact of cotrimoxazole and insecticide-treated nets for malaria prevention on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic review |
| Q36517673 | Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled study |
| Q35933924 | Insights Into Circulating Cytokine Dynamics During Pregnancy in HIV-Infected Beninese Exposed to Plasmodium falciparum Malaria |
| Q35108721 | Interactions between malaria and HIV infections in pregnant women: a first report of the magnitude, clinical and laboratory features, and predictive factors in Kinshasa, the Democratic Republic of Congo |
| Q34404275 | Interactions between malaria and human immunodeficiency virus anno 2014 |
| Q94569810 | Malaria Parasite Density as a Predictor of Hematological Parameter Changes among HIV Infected Adults Attending Two Antiretroviral Treatment Clinics in Kano, Northwest Nigeria |
| Q40375985 | Malaria Parasitemia and Parasite Density in Antiretroviral-Treated HIV-Infected Adults Following Discontinuation of Cotrimoxazole Prophylaxis |
| Q36147330 | Malaria infection and anaemia in HIV-infected children in Mutengene, Southwest Cameroon: a cross sectional study |
| Q37454296 | Non-treatment of children with community health worker-diagnosed fast-breathing pneumonia in rural Malawi: exploratory subanalysis of a prospective cohort study |
| Q41505058 | Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life |
| Q52689454 | Plasmodium falciparum diagnostic tools in HIV-positive under-5-year-olds in two ART clinics in Ghana: are there missed infections? |
| Q37279764 | Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria |
| Q58485600 | Prevalence and Predictors of Malaria in Human Immunodeficiency Virus Infected Patients in Beira, Mozambique |
| Q43642435 | Preventing malaria in HIV-infected pregnant women |
| Q39038490 | Prevention and control of malaria in pregnancy - new threats, new opportunities? |
| Q48514593 | Prevention of malaria in pregnancy |
| Q46129994 | Protective effect of indoor residual spraying of insecticide on preterm birth among pregnant women with HIV in Uganda: A secondary data analysis. |
| Q37723712 | Reasons for hospitalization in HIV-infected children in West Africa |
| Q38843752 | Safety and immunogenicity of RTS,S/AS01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trial |
| Q28538874 | Safety of daily co-trimoxazole in pregnancy in an area of changing malaria epidemiology: a phase 3b randomized controlled clinical trial |
| Q90295052 | Safety, tolerability, and immunogenicity of PfSPZ Vaccine administered by direct venous inoculation to infants and young children: findings from an age de-escalation, dose-escalation double-blinded randomized, controlled study in western Kenya |
| Q28125898 | Substantial increase in mutations in the genes pfdhfr and pfdhps puts sulphadoxine-pyrimethamine-based intermittent preventive treatment for malaria at risk in Burkina Faso |
| Q38330997 | The expanding role of co-trimoxazole in developing countries |
| Q64067248 | The prevalence and antifolate drug resistance profiles of Plasmodium falciparum in study participants randomized to discontinue or continue cotrimoxazole prophylaxis |
| Q35737444 | Trends in prevalence of diarrhoea, Kaposi's sarcoma, bacterial pneumonia, malaria and geohelminths among HIV positive individuals in Uganda |
Search more.